ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716970 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716970; 2) Community: the network communities that were significantly associated with the response to NSC 716970; 3) Molecule: the relationships between components within communities and NSC 716970; 4) MDR: the compounds that were significantly associated with the NSC 716970.

NSC Compound Enrichment Correlation
NSC 135925 Null 0.0119221520283057 0.2448245
NSC 153353 L-Alanosine 0.0119221520283057 0.26554446
NSC 382053 Null 0.0119221520283057 0.36210519
NSC 641387 Null 0.0119221520283057 0.16383874
NSC 674071 Null 0.0119221520283057 -0.003662889
NSC 678994 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- 0.0119221520283057 0.075931145
NSC 698395 Morpholine, 4,4'-(3,4-dichloro-2,4-dinitro-1,3-butadiene- 1,1-diyl)bis-, (1E,3E)- 0.0119221520283057 0.14303048
NSC 707148 Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) 0.0119221520283057 0.39616998
NSC 708244 Indolo[3,2-d]benzazepin-6(5H)-one, 9-cyano-2,3-dimethoxy-~7,12-dihydro- 0.0119221520283057 0.43164313
NSC 726973 Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-ethylamino}ethane Bis(trifluoroacetate) 0.0119221520283057 0.50765311
Total:95  Current:31    [First] [Prev] [Next] [Last]